Global Sickle Cell Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 149255
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 117
  • list Pharmaceuticals and Healthcare

The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.

Scope of the Report:

This report studies the Sickle Cell market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sickle Cell market by product type and applications/end industries.

The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.

The global Sickle Cell market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sickle Cell.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Novartis

Bristol-Myers Squibb

Shire

Bluebird Bio

Global Blood Therapeutics

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Diagnosis

Treatment

Market Segment by Applications, can be divided into

Hospitals

Clinics

Ambulatory Surgical Centers

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Sickle Cell Market Overview

1.1 Product Overview and Scope of Sickle Cell

1.2 Classification of Sickle Cell by Types

1.2.1 Global Sickle Cell Revenue Comparison by Types (2017-2023)

1.2.2 Global Sickle Cell Revenue Market Share by Types in 2017

1.2.3 Diagnosis

1.2.4 Treatment

1.3 Global Sickle Cell Market by Application

1.3.1 Global Sickle Cell Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Global Sickle Cell Market by Regions

1.4.1 Global Sickle Cell Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Sickle Cell Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Sickle Cell Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sickle Cell Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Sickle Cell Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sickle Cell Status and Prospect (2013-2023)

1.5 Global Market Size of Sickle Cell (2013-2023)

2 Manufacturers Profiles

2.1 Novartis

2.1.1 Business Overview

2.1.2 Sickle Cell Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novartis Sickle Cell Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bristol-Myers Squibb

2.2.1 Business Overview

2.2.2 Sickle Cell Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bristol-Myers Squibb Sickle Cell Revenue, Gross Margin and Market Share (2016-2017)

2.3 Shire

2.3.1 Business Overview

2.3.2 Sickle Cell Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Shire Sickle Cell Revenue, Gross Margin and Market Share (2016-2017)

2.4 Bluebird Bio

2.4.1 Business Overview

2.4.2 Sickle Cell Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bluebird Bio Sickle Cell Revenue, Gross Margin and Market Share (2016-2017)

2.5 Global Blood Therapeutics

2.5.1 Business Overview

2.5.2 Sickle Cell Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Global Blood Therapeutics Sickle Cell Revenue, Gross Margin and Market Share (2016-2017)

3 Global Sickle Cell Market Competition, by Players

3.1 Global Sickle Cell Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Sickle Cell Players Market Share

3.2.2 Top 10 Sickle Cell Players Market Share

3.3 Market Competition Trend

4 Global Sickle Cell Market Size by Regions

4.1 Global Sickle Cell Revenue and Market Share by Regions

4.2 North America Sickle Cell Revenue and Growth Rate (2013-2018)

4.3 Europe Sickle Cell Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Sickle Cell Revenue and Growth Rate (2013-2018)

4.5 South America Sickle Cell Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Sickle Cell Revenue and Growth Rate (2013-2018)

5 North America Sickle Cell Revenue by Countries

5.1 North America Sickle Cell Revenue by Countries (2013-2018)

5.2 USA Sickle Cell Revenue and Growth Rate (2013-2018)

5.3 Canada Sickle Cell Revenue and Growth Rate (2013-2018)

5.4 Mexico Sickle Cell Revenue and Growth Rate (2013-2018)

6 Europe Sickle Cell Revenue by Countries

6.1 Europe Sickle Cell Revenue by Countries (2013-2018)

6.2 Germany Sickle Cell Revenue and Growth Rate (2013-2018)

6.3 UK Sickle Cell Revenue and Growth Rate (2013-2018)

6.4 France Sickle Cell Revenue and Growth Rate (2013-2018)

6.5 Russia Sickle Cell Revenue and Growth Rate (2013-2018)

6.6 Italy Sickle Cell Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Sickle Cell Revenue by Countries

7.1 Asia-Pacific Sickle Cell Revenue by Countries (2013-2018)

7.2 China Sickle Cell Revenue and Growth Rate (2013-2018)

7.3 Japan Sickle Cell Revenue and Growth Rate (2013-2018)

7.4 Korea Sickle Cell Revenue and Growth Rate (2013-2018)

7.5 India Sickle Cell Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Sickle Cell Revenue and Growth Rate (2013-2018)

8 South America Sickle Cell Revenue by Countries

8.1 South America Sickle Cell Revenue by Countries (2013-2018)

8.2 Brazil Sickle Cell Revenue and Growth Rate (2013-2018)

8.3 Argentina Sickle Cell Revenue and Growth Rate (2013-2018)

8.4 Colombia Sickle Cell Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Sickle Cell by Countries

9.1 Middle East and Africa Sickle Cell Revenue by Countries (2013-2018)

9.2 Saudi Arabia Sickle Cell Revenue and Growth Rate (2013-2018)

9.3 UAE Sickle Cell Revenue and Growth Rate (2013-2018)

9.4 Egypt Sickle Cell Revenue and Growth Rate (2013-2018)

9.5 Nigeria Sickle Cell Revenue and Growth Rate (2013-2018)

9.6 South Africa Sickle Cell Revenue and Growth Rate (2013-2018)

10 Global Sickle Cell Market Segment by Type

10.1 Global Sickle Cell Revenue and Market Share by Type (2013-2018)

10.2 Global Sickle Cell Market Forecast by Type (2018-2023)

10.3 Diagnosis Revenue Growth Rate (2013-2023)

10.4 Treatment Revenue Growth Rate (2013-2023)

11 Global Sickle Cell Market Segment by Application

11.1 Global Sickle Cell Revenue Market Share by Application (2013-2018)

11.2 Sickle Cell Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Clinics Revenue Growth (2013-2018)

11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)

12 Global Sickle Cell Market Size Forecast (2018-2023)

12.1 Global Sickle Cell Market Size Forecast (2018-2023)

12.2 Global Sickle Cell Market Forecast by Regions (2018-2023)

12.3 North America Sickle Cell Revenue Market Forecast (2018-2023)

12.4 Europe Sickle Cell Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Sickle Cell Revenue Market Forecast (2018-2023)

12.6 South America Sickle Cell Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Sickle Cell Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Sickle Cell Picture

Table Product Specifications of Sickle Cell

Table Global Sickle Cell and Revenue (Million USD) Market Split by Product Type

Figure G

Please fill the form below, to recieve the report sample


+1